| Dr George H Khoury, MD | |
|
2145 Henry Tecklenburg Dr, Suite 220, Charleston, SC 29414-5893 | |
| (843) 723-8823 | |
| (843) 722-8124 |
| Full Name | Dr George H Khoury |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 44 Years |
| Location | 2145 Henry Tecklenburg Dr, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174582035 | NPI | - | NPPES |
| P00813606 | Other | SC | RAILROAD MEDICARE ID-RSFPN |
| P00656018 | Other | SC | RAILROAD MEDICAID # |
| 103505 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 10350 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Roper-st. Francis Home Health | Charleston, SC | Home health agency |
| Bon Secours-st Francis Xavier Hospital | Charleston, SC | Hospital |
| Roper Hospital | Charleston, SC | Hospital |
| Roper St Francis Hospital-berkely Inc | Moncks corner, SC | Hospital |
| Mount Pleasant Hospital | Mount pleasant, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roper Saint Francis Physicians Network | 5193874824 | 415 |
News Archive
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.
"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.
GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.
› Verified 6 days ago
| Entity Name | Roper Saint Francis Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346752383 PECOS PAC ID: 5193874824 Enrollment ID: O20090528000405 |
News Archive
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.
"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.
GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George H Khoury, MD Po Box 751649, Charlotte, NC 28275-1649 Ph: (843) 789-1620 | Dr George H Khoury, MD 2145 Henry Tecklenburg Dr, Suite 220, Charleston, SC 29414-5893 Ph: (843) 723-8823 |
News Archive
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.
"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.
GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.
› Verified 6 days ago
Dr. Matthew T Neal, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 | |
Steven Steuer Glazier, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. John D Steichen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 Fax: 843-606-8059 | |
Ricardo Alfonso Domingo Cabreja, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2424 | |
Clayton Lee Haldeman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 | |
Dr. Sunil J Patel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Stephen Robert Lowe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-792-1414 Fax: 843-792-9295 |